Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/2191| Meeting the Potential Emergency Global Drug Supply Challenge of Hydroxychloroquine for COVID-19 | |
| Zhang Tony Y.. Zhong Boyu. | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| 10.1016/j.medidd.2020.100036 | |
| Highlights• In this timely perspective provided by two pharmaceutically industry veterans, the current global market of hydroxychloroquine, a drug currently being investigated for the treatment of patient inflicted with COVID-19 corona virus, and the ability of manufacturers to meet the potential surge in demand, are delineated with ample data. Whether hydroxychloroquine is ultimately efficacious against COVID-19 will be decided by large scale and controlled clinical trials. Whether this drug can be made accessible to the global patients in need will require careful planning of global government and industrial leaders. At this critical time, we hope their voice can be heard by the policy makers and stakeholders alike | |
| Medicine in Drug Discovery | |
| 2020 | |
| Artículo | |
| https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144509/pdf/main.pdf | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| 1101254.pdf | 3.24 MB | Adobe PDF | Visualizar/Abrir |